Impact of Employee Health Promotion Course on Health Promotion in the Work Place.

April 23, 2023 updated by: Donna R Zwas, Hadassah Medical Organization

Impact of Health Promotion Course for Female Employees on Health Promotion in the Work Place.

People of working age spend most of their day at work, and usually have less time to participate in other activities, the work day in Israel being one of the longest in the OECD. Work places, therefore, present the most suitable setting for health interventions, as they are an accessible and available framework and have real potential of creating change.

The current Health Promotion in the Work Place training course aims to train female employees to design, implement, and evaluate a health promotion program in their workplace, as well as promote personal change in improving healthy habits, and empowering the participants. A unique course has been designed, consisting of 20 sessions- 15 consecutive sessions, and 5 maintenance sessions throughout the year. The course will focus on acquiring health knowledge and health promotion skills, as well as leadership skills and empowerment.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Active, not recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Poor health of employees can cause absences, lack of continuous service, decreased output or productions, fatigue or lack of concentration, and eventually financial damage to the employer. Research shows that health promotion programs in the work place improve employee's physical and emotional health, as well as their sense of commitment, belonging, and responsibility.

People of working age spend most of their day at work, and usually have less time to participate in other activities, the work day in Israel being one of the longest in the OECD. Work places, therefore, present the most suitable setting for health interventions, as they are an accessible and available framework and have real potential of creating change.

The current Health Promotion in the Work Place training course aims to train female employees to design, implement, and evaluate a health promotion program in their workplace, as well as promote personal change in improving healthy habits, and empowering the participants. Objectives include improving eating habits, increasing engagement in physical activity, increasing self-efficacy, and designing a detailed health promotion program in the work place, based on it's needs, and implementing it there.

In order to accomplish these objectives, a unique course has been designed, consisting of 20 sessions- 15 consecutive sessions, and 5 maintenance sessions throughout the year. The course will focus on acquiring health knowledge and health promotion skills, as well as leadership skills and empowerment. The participants will learn how to build programs, market them to their coworkers and employers, budget them, recruit partners, create a Gantt charts, implement and evaluate. The maintenance sessions will take place in different work places, so that the participants can showcase their projects.

Data will be collected at baseline and 2 post interventions follow up points (after 15 weeks and after one year).

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Anticipated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
45

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Israel
      • Jerusalem, Israel, 91120
        • Hadassah Medical Organization, Jerusalem, Isreal

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Female employees from governmental offices and private organizations, willingness to commit to participation in the health promotion training course and lead a health promotion project in their place of work, willingness to make make personal change.

Exclusion Criteria:

  • None.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Health Promotion Training for Women Employees
Groups of women employees will participate in a 20 session health promotion training course. The course will include health education and health promotion knowledge and skills, as well as leadership and project building skills, including empowerment, change process, recruiting partners and more. The first 15 sessions will be weekly session, while the remaining five will take place every couple of months throughout the following year.
Behavioral: Health Promotion Training for Women Employees
Group intervention over a one year, acquiring health promotion tools and skills, as well as leadership and project designing and implementation skills.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Change in Nutrition Habits
Time Frame: At baseline, 15 weeks after intervention initiation, and one year post intervention.
Participants complete self report survey indicating their eating habits, including consumption of sweets, sweet beverages, fruits and vegetables, whole grains, and legumes.
At baseline, 15 weeks after intervention initiation, and one year post intervention.
Change in Physical Activity Habits
Time Frame: At baseline, 15 weeks after intervention initiation, and one year post intervention.
Participants complete self report survey indicating their physical activity habits, including minutes of engaging in vigorous and moderate physical activity. Measures will include average daily minutes of engaging in physical activity, and adherence to WHO recommendation (150 minutes of moderate physical activity a week, or 75 minutes of vigorous physical activity a week).
At baseline, 15 weeks after intervention initiation, and one year post intervention.
Health Promotion projects in the Work Place
Time Frame: One year post intervention
Each participant will have implemented a health promotion project in their workplace, according to the timeline and goals defined in each project. This will be assessed through phone interviews with the participants.
One year post intervention

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Change in Self Efficacy
Time Frame: At baseline, 15 weeks after intervention initiation, and one year post intervention.
Self Efficacy will be assessed through self report questionnaires, assessing participants self efficacy regarding their leadership skills, ability to implement a health promotion project, create partnerships, evaluate a project, and influence women in their community.
At baseline, 15 weeks after intervention initiation, and one year post intervention.
Change in cardiovascular disease knowledge
Time Frame: At baseline, 15 weeks after intervention initiation, and one year post intervention.
Cardiovascular disease knowledge will be assessed through a self report questionnaire based on the American Heart Association's Cardiovascular disease knowledge survey items
At baseline, 15 weeks after intervention initiation, and one year post intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Hadassah Medical Organization

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Donna R Zwas, MD, Hadassah Medical Organization

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 1, 2017

Primary Completion (Anticipated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
September 1, 2024

Study Completion (Anticipated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
September 1, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
September 24, 2017

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 24, 2017

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
September 27, 2017

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
April 25, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 23, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • WRK-HMO-CTIL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Knowledge, Attitudes, Practice

Clinical Trials on Health Promotion Training for Women Employees

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings